What about HES in burn patients?: Evaluation of the actual evidence

dc.contributor.authorGuilabert, Patricia
dc.contributor.authorAbarca, Luis
dc.contributor.authorMartin, Nuria
dc.contributor.authorUsua, Gemma
dc.contributor.authorBarret Nerín, Juan Pedro
dc.contributor.authorColomina Soler, M. J. (María José)
dc.date.accessioned2018-05-22T12:49:53Z
dc.date.available2019-05-31T05:10:12Z
dc.date.issued2018-05
dc.date.updated2018-05-22T12:49:53Z
dc.description.abstractFollowing the 2013 alert by the European Medicines Agency (EMA) discouraging the use of hydroxyethyl-starch solutions (HES) in critically ill and burn patients, most specialized units treating burn victims have stopped using HES in this population. But, how well-founded was the EMA alert in this specific type of patient? ...
dc.format.extent5 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec676941
dc.identifier.issn0305-4179
dc.identifier.pmid29029856
dc.identifier.urihttps://hdl.handle.net/2445/122487
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.burns.2017.09.023
dc.relation.ispartofBurns, 2018, vol. 44, num. 3, p. 489-493
dc.relation.urihttps://doi.org/10.1016/j.burns.2017.09.023
dc.rightscc-by-nc-nd (c) Elsevier B.V., 2018
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es
dc.sourceArticles publicats en revistes (Ciències Clíniques)
dc.subject.classificationCremades
dc.subject.classificationMedicaments
dc.subject.classificationMalalts en estat crític
dc.subject.otherBurns and scalds
dc.subject.otherDrugs
dc.subject.otherCritically ill
dc.titleWhat about HES in burn patients?: Evaluation of the actual evidence
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
676941.pdf
Mida:
235.39 KB
Format:
Adobe Portable Document Format